Explain this page
Arphra AIPlain-English read on VeriSign, Inc.’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Headline | ||||||||
| Market cap | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — |
| Multiples | ||||||||
| P / E | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
| Yields | ||||||||
| Earnings yield | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin | +85.54% | +85.91% | +86.79% | +87.71% | +88.15% | +89.00% | +89.54% | +88.57% |
| Operating margin | +65.29% | +66.19% | +67.01% | +67.95% | +67.67% | +65.58% | +66.44% | +66.60% |
| EBITDA margin | +68.80% | +70.35% | +73.40% | +72.82% | +70.72% | +71.45% | +71.68% | +74.46% |
| EBIT margin | +65.19% | +67.06% | +70.44% | +70.45% | +68.83% | +69.93% | +70.58% | +71.15% |
| Pre-tax margin | +58.92% | +61.77% | +65.40% | +65.62% | +64.50% | +67.03% | +66.63% | +65.73% |
| Net margin | +59.12% | +47.29% | +54.76% | +50.45% | +49.84% | +51.10% | +52.93% | +52.57% |
| Cost structure | ||||||||
| Cost of revenue / sales | +14.46% | +14.09% | +13.21% | +12.29% | +11.85% | +12.67% | +12.30% | +12.48% |
| R&D intensity | +6.07% | +6.01% | +6.09% | +6.21% | +6.25% | +6.35% | +6.14% | +6.24% |
| SG&A intensity | +14.18% | +13.71% | +13.68% | +13.55% | +14.23% | +13.91% | +13.96% | +13.96% |
| Effective tax rate | -0.33% | +23.45% | +16.27% | +23.11% | +22.72% | +20.48% | +20.67% | +20.49% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Returns | ||||||||
| Return on equity (ROE) | -62.26% | -43.13% | -51.71% | -40.13% | -38.33% | -41.29% | -41.40% | -41.15% |
| Return on assets (ROA) | +39.56% | +38.87% | +46.75% | +55.86% | +62.27% | +52.72% | +54.04% | +54.34% |
| Return on capital (ROC) | +164.26% | +405.11% | +462.17% | -676.60% | -314.71% | -651.31% | -632.55% | -599.38% |
| Return on invested capital (ROIC) | +148.72% | +289.43% | +377.64% | -502.37% | -231.81% | -507.53% | -503.91% | -473.10% |
| Asset turnover | +66.92% | +82.20% | +85.37% | +110.73% | +124.94% | +103.16% | +102.10% | +103.37% |
| DuPont · ROE decomposition | ||||||||
| Net margin | +59.12% | +47.29% | +54.76% | +50.45% | +49.84% | +51.10% | +52.93% | +52.57% |
| Asset turnover (× revenue / assets) | +66.92% | +82.20% | +85.37% | +110.73% | +124.94% | +103.16% | +102.10% | +103.37% |
| Equity multiplier (× assets / equity) | -157.38% | -110.96% | -110.63% | -71.84% | -61.55% | -78.33% | -76.61% | -75.73% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Asset turnover | 0.67 | 0.82 | 0.85 | 1.11 | 1.25 | 1.03 | 1.02 | 1.03 |
| Fixed-asset turnover | 5.11 | 5.96 | 6.21 | 6.66 | 7.41 | — | — | — |
| Inventory turnover | — | — | — | — | — | — | — | — |
| Receivables turnover | 102.49 | 175.91 | 109.79 | 199.67 | 111.18 | — | — | — |
| Payables turnover | 21.33 | 20.48 | 15.78 | 18.06 | 14.22 | — | — | — |
| Days outstanding | ||||||||
| Days sales outstanding (DSO) | 3.56 | 2.07 | 3.32 | 1.83 | 3.28 | — | — | — |
| Days inventory outstanding (DIO) | — | — | — | — | — | — | — | — |
| Days payables outstanding (DPO) | 17.12 | 17.82 | 23.12 | 20.21 | 25.66 | — | — | — |
| Cash conversion cycle | -13.55 | -15.75 | -19.80 | -18.39 | -22.38 | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 1.03 | 1.23 | 1.04 | 1.15 | 1.32 | 1.21 | 1.11 | 1.18 |
| FCF / Net income | 0.96 | 1.19 | 0.99 | 1.11 | 1.29 | 1.15 | 1.07 | 1.12 |
| FCF margin | +56.80% | +56.40% | +54.12% | +56.15% | +64.49% | +58.88% | +56.86% | +58.90% |
| OCF margin | +60.80% | +58.33% | +57.18% | +57.96% | +65.86% | +61.77% | +58.82% | +61.97% |
| CapEx / Revenue | +3.99% | +1.92% | +3.07% | +1.80% | +1.38% | +2.05% | +2.14% | +2.12% |
| CapEx / D&A | 1.11 | 0.58 | 1.04 | 0.76 | 0.73 | — | — | — |
| Stock-based comp / Revenue | +4.02% | +4.11% | +4.00% | +3.92% | +4.21% | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 7.00 | 6.24 | 7.90 | 8.00 | 8.81 | 9.69 | 10.67 | 12.40 |
| EPS · basic | 7.01 | 6.24 | 7.91 | 8.01 | 8.83 | 9.79 | 10.61 | 12.24 |
| Book value / share | -11.24 | -14.46 | -15.28 | -19.94 | -23.26 | -23.23 | -25.68 | -28.30 |
| Tangible BV / share | -11.71 | -14.95 | -15.78 | -20.47 | -25.40 | -23.23 | -25.68 | -28.30 |
| Sales / share | 11.84 | 13.19 | 14.43 | 15.86 | 17.89 | 18.77 | 20.09 | 22.16 |
| Operating CF / share | 7.20 | 7.70 | 8.25 | 9.19 | 11.78 | 11.59 | 11.82 | 13.73 |
| Free cash flow / share | 6.72 | 7.44 | 7.81 | 8.91 | 11.54 | 11.05 | 11.42 | 13.05 |
| Dividends / share | 0.00 | 0.00 | 0.00 | 0.00 | 2.32 | 0.82 | 0.85 | 0.94 |
| Payout ratio | 0.00% | 0.00% | 0.00% | 0.00% | +26.06% | +8.57% | +7.96% | +8.04% |
| Retention ratio | +100.00% | +100.00% | +100.00% | +100.00% | +73.94% | +91.43% | +92.04% | +91.96% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 7y CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Top-line | |||||||||
| Revenue · YoY | — | +7.33% | +4.79% | +4.31% | +6.37% | +5.03% | +6.55% | +9.80% | +6.30% |
| Gross profit · YoY | — | +7.80% | +5.85% | +5.42% | +6.90% | +6.05% | +7.20% | +8.60% | +6.82% |
| Profit | |||||||||
| Operating income · YoY | — | +8.80% | +6.10% | +5.76% | +5.93% | +1.79% | +7.95% | +10.06% | +6.60% |
| EBITDA · YoY | — | +9.74% | +9.33% | +3.49% | +3.30% | +6.12% | +6.89% | +14.07% | +7.50% |
| Net income · YoY | — | -14.14% | +21.34% | -3.90% | +5.09% | +7.69% | +10.36% | +9.05% | +4.53% |
| Operating | |||||||||
| EBIT · YoY | — | +10.40% | +10.08% | +4.32% | +3.93% | +6.70% | +7.54% | +10.69% | +7.63% |
| R&D · YoY | — | +6.42% | +6.18% | +6.26% | +7.14% | +6.71% | +2.92% | +11.64% | +6.73% |
| Per-share | |||||||||
| EPS · diluted · YoY | — | -10.86% | +26.60% | +1.27% | +10.13% | +9.97% | +10.18% | +16.19% | +8.52% |
| EPS · basic · YoY | — | -10.98% | +26.76% | +1.26% | +10.24% | +10.92% | +8.29% | +15.44% | +8.29% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Leverage | ||||||||
| Total debt | $1.79B | $1.8B | $1.8B | $1.8B | $1.8B | $1.98B | $2.18B | $2.37B |
| Net debt | $1.56B | $1.42B | $1.56B | $1.59B | $1.49B | $1.69B | $1.88B | $2.04B |
| Net debt / EBITDA | 1.71 | 1.42 | 1.42 | 1.41 | 1.27 | 1.36 | 1.41 | 1.35 |
| Debt / equity | -1.42 | -1.15 | -1.14 | -0.92 | -0.83 | -0.92 | -0.92 | -0.91 |
| Debt / assets | +90.14% | +103.55% | +102.77% | +128.08% | +135.61% | +117.28% | +119.80% | +120.56% |
| Equity / assets | -63.54% | -90.12% | -90.39% | -139.20% | -162.47% | -127.67% | -130.52% | -132.05% |
| Coverage | ||||||||
| EBITDA / interest expense | 10.97 | 13.31 | 14.55 | 15.06 | 15.21 | 14.72 | 14.52 | 15.62 |
| Operating income / interest | 10.41 | 12.52 | 13.29 | 14.05 | 14.56 | 13.51 | 13.46 | 13.98 |
| Interest expense | $83.26M | $75.3M | $75.3M | $75.3M | $77M | $84.48M | $91.5M | $97.01M |
| Liquidity | ||||||||
| Current ratio | 1.18 | 0.93 | 0.83 | 0.43 | 0.49 | — | — | — |
| Quick ratio | 1.13 | 0.89 | 0.79 | 0.40 | 0.45 | — | — | — |
| Cash ratio | 0.21 | 0.33 | 0.20 | 0.14 | 0.23 | — | — | — |
| Working capital | $194.74M | -$78.2M | -$200.2M | -$867.3M | -$680.6M | — | — | — |
| Working capital / revenue | +14.67% | -5.49% | -13.41% | -55.69% | -41.08% | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).